Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials.
Tóm tắt
Từ khóa
Tài liệu tham khảo
Horn CR, Clark TJH, Cochrane GM. Inhaled therapy reduces morning dips in asthma. Lancet 1984;i: 1 143-5.
Hume KM, Rhys Jones E. Bronchodilators and corticosteroids in asthma. Forced expiratory volume as an aid to diagnosis and treatment. Lancet 1960;ii:1319-22.
Juniper EF, Kline PA, Vanzieleghen MA, Ramsdale EH, O'Byrne PM, Hargreave FE. Effect oflong-term treatment with an inhaled steroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid dependent asthmatics. Am Rev Respir Dis 1990;142: 832-6.
Busse WW, Wilson AF. Taskforce on guidelines for clinical investigation of nonbronchodilator antiasthmatics drugs. Assessment of efficacy. J Allergy Giun Immunol 1986; 78:525-8.
Juniper EF, Daniel EE, Roberts RS, Kline PA, Hargreave FE, Newhouse MT. Improvement in airway responsiveness and asthma severity during pregnancy. Am Rev Respir Dis 1989;140:924-31.
Kirshner B, Guyatt GH. A methodologic framework for assessing health indices. Journal of Chronic Diseases 1985;38:27-36.
Guyatt GH, Bombardier C, Tugwell PX. Measuring disease-specific quality of life in clinical trials. Can Med Assoc J 1986;134:889-95.
Kinsman RA, Luparello T, O'Banion K, Spector S. Multidimensional analysis of the subjective symptomatology of asthma. Psychosom Med 1973;35:250-67.
Bergner M, Bobbit RA, Carter WB, Gilson BS. The sickness impact profile: development and final revision of a health status measure. Med Care 1981;19:787-805.
Guyatt GH, Townsend M, Berman LB, Pugsley SO. Quality of life in patients with chronic airflow limitation. British Journal of Diseases of the Chest 1987;81:45-54.
Juniper EF, Frith PA, Hargreave FE. Airway responsiveness to histamine and methacholine: relationship to minimum treatment to control symptoms of asthma. Thorax 1981;36:575-9.
Juniper EF, Frith PA, Hargreave FE. Reproducibility and comparison of responses to inhaled histamine and methacholine. Thorax 1978;33:705-10.
Guyatt GH, Townsend M, Berman LB, Keller JL. A comparison of likert and visual analogue scales for measuring change in function. Journal of Chronic Diseases 1987;40:1 129-33.
Jaeschke R, Singer J, Guyatt GH. A comparison of seven point and visual analogue scales: data from a randomised trial. Controlled Clin Trials 1990;11:43-51.
Guyatt GH, Berman LB, Townsend M, TaylorDW. Should study subjects see their previous responses? Journal of Chronic Diseases 1985;38:1003-7.
Guyatt GH, Townsend M, Keller JL, Singer J. Should study subjects see their previous responses? Data from a randomised control trial. J Clin Epidemiol 1989;42: 913-20.
Juniper EF, Guyatt GH. Development and testing of a new measure ofhealth status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy 1991;21:77-83.
Josephs LK, Gregg I, Mullee MA, Holgate ST. Nonspecific bronchial reactivity and its relationship to the clinical expression ofasthma. Am Rev Respir Dis 1989;140:350-7.
Hargreave FE, Thomson NC, O'Byrne PM, Latimer K, Juniper EF, Dolovich J. Bronchial responsiveness to histamine and methacholine; measurement and clinical significance. J Allergy Clin Immunol 1981;68:347-55.
Juniper EF, Daniel EE, Roberts RS, Kline PA, Hargreave FE, Newhouse MT. Improvement in airway responsiveness and asthma severity during pregnancy. Am Rev Respir Dis 1989;140:924-31.
Guyatt GH, Norgradi S, Halcrow S, Singer J, Sullivan MJJ, Fallen EL. Development and testing of a new measure of health status for clinical trials in heart failure. J Gen Intern Med 1989;4:101-7.
Levine MN, Guyatt GH, Gent M, DePauws S, Goodyear MD. Quality of life in stage II breast cancer: an instrument for clinical trials. J Clin Oncol 1988;6: 1798-810.